Cryptic B-cell epitope identification through informational analysis of protein sequenses

Vaccine

Volumn 25, Issue 14, 2007, Pages 2688-2697

  Alekseeva, Ludmila ^a   Nekrasov, Aleksei ^a   Marchenko, Aleksei ^b   Shevchenko, Marina ^a   Benevolenskii, Sergei ^b   Sapozhnikov, Alexander ^a   Kurup, Viswanath P ^c   Svirshchevskaya, Elena ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

^c CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

B cell epitopes; Information structure of proteins; Virus like particles

Indexed keywords

ALANYLTRYPTOPHYLGLYCYLLYSYLALANYLASPARAGINYLGLUTAMINYLVALYL THREONYLGLYCYLASPARTYLASPARTYLISOLEUCYLLEUCYLPHENYLALANINE; ASPARAGINYLHISTIDYLLEUCYLGLUTAMYLPHENYLALANYLSERYLSERYLALANYL GLUTAMYLTHREONYLVALYLLEUCYLLYSYLHISTIDYLLEUCINE; ASPARTYLGLUTAMINYLGLYCYLHISTIDYLASPARTYLTHREONYL GLYCYLSERYLALANYLSERYLALANYLPROLYLALANYLSERYLTHREONINE; B LYMPHOCYTE ANTIGEN; EPITOPE; GLUTAMYLLEUCYLALANYLARGINYLHISTIDYLALANYLLYSYLALANYL HISTIDYLISOLEUCYLLEUCYLARGININE; GLUTAMYLTYROSYLISOLEUCYLGLUTAMYLLYSYLLEUCYLPROLYL GLUTAMYLISOLEUCYLARGINYLALANYLLYSYLGLYCYLVALYLASPARTIC ACID; GLYCYLALANYLVALYLTHREONYLSERYLPHENYLALANYLPROLYLISOLEUCYL HISTIDYLSERYLSERYLCYSTEINYLASPARAGINYLALANYLTHREONYLGLUTAMINYL ARGINYLARGINYLGLUTAMINYLISOLEUCYLGLUTAMYLALANINE; GLYCYLTRYPTOPHYLALANYLASPARTYLGLUTAMYLGLUTAMYLGLYCYLARGINYL THREONYLLYSYLARGINYLTYROSYLALANYLLEUCYLVALINE; GLYCYLTRYPTOPHYLGLYCYLGLYCYLHISTIDYLTRYPTOPHYLARGINYLGLYCYL ALANYLASPARAGINYLALANYLTHREONYLSERYLGLUTAMYLTHREONINE; GLYCYLTRYPTOPHYLVALYLASPARTYLHISTIDYLPHENYLALANYLALANYL ASPARTYLGLYCYLTYROSYLASPARTYLGLUTAMYLVALYLISOLEUCYLALANINE; IMMUNOGLOBULIN; LYSYLISOLEUCYLTHREONYLTYROSYLALANYLALANYLLEUCYLGLUTAMYLPROLYL ALANYLLYSYLASPARAGINYLHISTIDYLLEUCINE; LYSYLSERYLASPARAGINYLGLYCYLTHREONYLGLUTAMYLSERYLTHREONYL HISTIDYLASPARTYLSERYLGLUTAMYLALANYLPHENYLALANYLGLUTAMIC ACID; LYSYLVALYLISOLEUCYLLEUCYLPHENYLALANYLALANYLLEUCYLPROLYL GLYCYLALANYLPHENYLALANYLTHREONYLPROLYLVALYLCYSTEINE; METHIONYLGLUTAMYLALANYLVALYLGLYCYLALANYLTYROSYL ASPARTYLVALYLISOLEUCYLVALYLASPARAGINE; METHIONYLSERYLGLYCYLLEUCYLLYSYLALANYLGLYCYLASPARTYLSERYLPHENYL ALANYLPROLYLSERYLASPARTYLVALYLVALINE; PEPTIDE; PHENYLALANYLSERYLTYROSYLISOLEUCYLPROLYLTRYPTOPHYLSERYL GLUTAMYLASPARTYLLYSYLGLYCYLGLUTAMYLISOLEUCYLTHREONYLALANINE; PROLYLASPARTYLALANYLARGINYLPHENYLALANYLSERYLLYSYLSERYLISOLEUCYL GLYCYLTRYPTOPHYLALANINE; PROLYLISOLEUCYLASPARAGINYLTYROSYLASPARAGINYLALANYLSERYLLYSYL GLUTAMYLTRYPTOPHYLALANYLASPARTYLLYSINE; PROLYLSERYLASPARAGINYLCYSTEINYLHISTIDYLTHREONYLHISTIDYL GLUTAMYLGLYCYLGLYCYLGLUTAMINYLLEUCYLHISTIDYLCYSTEINYLTHREONINE; RECOMBINANT PROTEIN; SERYLASPARTYLLEUCYLMETHIONYLHISTIDYLARGINYLLEUCYLTYROSYL HISTIDYLVALYLPROLYLALANYLVALYLGLYCYLGLUTAMINE; SERYLGLUTAMYLISOLEUCYLTYROSYLARGINYLLYSYLTYROSYLPHENYLALANYL GLYCYLASPARAGINYLARGINYLPROLINE; SERYLGLYCYLSERYLGLYCYLALANYLTHREONYLTHREONYLTHREONYLPROLYL THREONYLASPARTYLSERYLPROLYLSERYLALANINE; TYROSYLTHREONYLTHREONYLARGINYLARGINYLTRYPTOPHYLLEUCYLVALYLSERYL METHIONYLCYSTEINYLSERYLGLUTAMINYLGLYCYLTYROSINE; UNCLASSIFIED DRUG; VALYLVALYLALANYLVALYLLEUCYLALANYLTYROSYLASPARAGINYL ASPARTYLALANYLTYROSYLVALYLMETHIONYLSERYLALANINE;

AMINO ACID SEQUENCE; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; COMPARATIVE STUDY; CONTROLLED STUDY; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; VIRUS LIKE AGENT; YEAST;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; EPITOPES, B-LYMPHOCYTE; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, PROTEIN; VACCINES; VIRION;

EID: 33947269306     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.07.003     Document Type: Article

References (38)

1. Focke M., Linhart B., Hartl A., Wiedermann U., Sperr W.R., Valent P., et al. Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination. Clin Exp Allergy 34 10 (2004) 1525-1533
2. Saarne T., Kaiser L., Gronlund H., Rasool O., Gafvelin G., and van Hage-Hamsten M. Rational design of hypoallergens applied to the major cat allergen Fel d 1. Clin Exp Allergy 35 5 (2005) 657-663
3. Francis J.N., and Larche M. Peptide-based vaccination: where do we stand?. Curr Opin Allergy Clin Immunol 5 6 (2005) 537-543
4. Dunn C., O'Dowd A., and Randall R.E. Fine mapping of the binding sites of monoclonal antibodies raised against the Pk tag. J Immunol Meth 224 (1999) 141-150
5. Banerjee B., Kurup V.P., Greenberger P.A., Kelly K.J., and Fink J.N. C-terminal cysteine residues determine the IgE binding of Aspergillus fumigatus allergen Asp f 2. J Immunol 169 9 (2002) 5137-5144
6. Hopp T., and Woods K. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 78 (1981) 3824-3828
7. Welling G., Weijer W., Zee R., and Welling-Wester S. Prediction of sequential antigenic regions in proteins. FEBS Lett 188 (1985) 215-218
8. Parker J., Guo D., and Hodges R. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 25 (1986) 5425-5432
9. Novotny J., Handschumacher M., Haber E., Bruccoleri R., Carlson W., Fanning D., et al. Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains). Proc Natl Acad Sci USA 83 (1986) 226-230
10. Blythe M.J., and Flower D.R. Benchmarking B cell epitope prediction: underperformance of existing methods. Protein Sci 14 1 (2005) 246-248
11. Ramachandran H., Jayaraman V., Banerjee B., Greenberger P.A., Kelly K.J., Fink J.N., et al. IgE binding conformational epitopes of Asp f 3, a major allergen of Aspergillus fumigatus. Clin Immunol 103 (2002) 324-333
12. Hu H., Li L., Kao R.Y., Kou B., Wang Z., Zhang L., et al. Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library. J Comb Chem 7 5 (2005) 648-656
13. Lougovskoi A.A., Okoyeh N.J., and Chauhan V.S. Mice immunized with synthetic peptide from N-terminal conserved region of merozoite surface antigen-2 of human malaria parasite Plasmodium falciparum can control infection induced by Plasmodium yoelii yoelii 265BY strain. Vaccine 18 9-10 (1999) 920-930
14. Nekrasov A.N. Analysis of information structure of protein sequences: a new method for analyzing the domain organization of proteins. J Biomol Struct Dyn 21 (2004) 615-623
15. Rogov S.I., and Nekrasov A.N. A numerical measure of amino acid residues similarity based on the analysis of their surroundings in natural protein sequences. Protein Eng 14 (2001) 459-463
16. Nekrasov A.N. Entropy of protein sequences: an integral approach. J Biomol Struct Dyn 20 (2002) 87-92
17. Takagaki Y., Hirayama A., Fujio H., and Amano T. Antibodies to a continuous region at residues 38-54 of hen egg white lysozyme found in a small fraction of anti-hen egg white lysozyme antibodies. Biochemistry 19 11 (1980) 2498-2505
18. Rodda S.J., Geysen H.M., Mason T.J., and Schoofs P.G. The antibody response to myoglobin. I. Systematic synthesis of myoglobin peptides reveals location and substructure of species-dependent continuous antigenic determinants. Mol Immunol 23 6 (1986) 603-610
19. Altschuh D., Al Moudallal Z., Briand J.P., and Van Regenmortel M.H. Immunochemical studies of tobacco mosaic virus. VI. Attempts to localize viral epitopes with monoclonal antibodies. Mol Immunol 22 3 (1985) 329-337
20. Bernard A., Coitot S., Bremont A., and Bernard G. T and B cell cooperation: a dance of life and death. Transplantation 79 3 Suppl (2005) S8-S11
21. Benson E.M., Clarkson J., Law M., Marshall P., Kelleher A.D., Smith D.E., et al. Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individuals. AIDS Res Hum Retroviruses 15 (1999) 105-113
22. Oliveira-Ferreira J., Miyahira Y., Layton G.T., Savage N., Esteban M., Rodriguez D., et al. Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus. Vaccine 18 (2000) 1863-1869
23. Svirshchevskaya E.V., Viskova N., Shevchenko M., Alekseeva L., Marchenko A., Benevolensky S., et al. High-affinity IgG to a major A. fumigatus allergen, Asp f 2, retards allergic response. Med Sci Monit 10 10 (2004) BR371-BR380
24. Banerjee B., Greenberger P.A., Fink J.N., and Kurup V.P. Conformational and linear B-cell epitopes of Asp f 2, a major allergen of Aspergillus fumigatus, bind differently to immunoglobulin E antibody in the sera of allergic bronchopulmonary aspergillosis patients. Infect Immun 67 5 (1999) 2284-2291
25. Banerjee B., Kurup V.P., Phadnis S., Greenberger P.A., and Fink J.N. Molecular cloning and expression of a recombinant Aspergillus fumigatus protein Asp f II with significant immunoglobulin E reactivity in allergic bronchopulmonary aspergillosis. J Lab Clin Med 127 (1996) 253-262
26. Kurup V.P., Banerjee B., Hemmann S., Greenberger P.A., Blaser K., and Crameri R. Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin Exp Allergy 30 (2000) 988-993
27. Marchenko A.N., Kozlov D.G., Svirshchevskaya E.V., and Benevolensky S.V. The p1 protein of the yeast transposon Ty1 can be used for constructing bifunctional virus-like particles. JMMB 5 (2003) 97-104
28. Burms N.R., Gilmour J.E., Kingsman S.M., Kingsman A.J., and Adams S.E. Production and purification of hybrid Ty-VLPs. Mol Biotechnol 1 (1994) 137-145
29. Svirshchevskaya E.V., Alekseeva L., Marchenko A., Viskova N., Andronova T.M., Benevolenskii S.V., et al. Immune response modulation by recombinant peptides expressed in virus-like particles. Clin Exp Immunol 127 2 (2002) 199-205
30. Takai T., Kato T., Yasueda H., Okumura K., and Ogawa H. Analysis of the structure and allergenicity of recombinant pro- and mature Der p 1 and Der f 1: major conformational IgE epitopes blocked by prodomains. J Allergy Clin Immunol 115 (2005) 555-563
31. Saha S., Bhasin M., and Raghava G.P. Bcipep: a database of B-cell epitopes. BMC Genomics 6 1 (2005) 79-85
32. Schonbach C., Koh J.L., Flower D.R., and Brusic V. An update on the functional molecular immunology (FIMM) database. Appl Bioinformatics 4 1 (2005) 25-31
33. Loset G.A., Roux K.H., Zhu P., Michaelsen T.E., and Sandlie I. Differential segmental flexibility and reach dictate the antigen binding mode of chimeric IgD and IgM: implications for the function of the B cell receptor. J Immunol 172 (2004) 2925-2934
34. Wu B., Toussaint G., Vander Elst L., Granier C., Jacquemin M.G., and Saint-Remy J.M. Major T cell epitope-containing peptides can elicit strong antibody responses. Eur J Immunol 30 (2000) 291-299
35. Schmid-Grendelmeier P., Fluckiger S., Disch R., Trautmann A., Wuthrich B., Blaser K., et al. IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol 115 (2005) 1068-1075
36. Xiao Y., Lu Y., and Chen Y.H. Epitope-vaccine as a new strategy against HIV-I mutation. Immunol Lett 77 (2001) 3-6
37. Meng J., Dai X., Chang J.C., Lopareva E., Pillot J., Fields H.A., et al. Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology 288 (2001) 203-211
38. Corcoran A., Mahon B.P., and Doyle S. B cell memory is directed toward conformational epitopes of parvovirus B19 capsid proteins and the unique region of VP1. J Infect Dis 189 (2004) 1873-1880